148 related articles for article (PubMed ID: 20646320)
1. An open cohort study of bone metastasis incidence following surgery in breast cancer patients.
Koizumi M; Yoshimoto M; Kasumi F; Iwase T
BMC Cancer; 2010 Jul; 10():381. PubMed ID: 20646320
[TBL] [Abstract][Full Text] [Related]
2. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
[TBL] [Abstract][Full Text] [Related]
3. What do breast cancer patients benefit from staging bone scintigraphy?
Koizumi M; Yoshimoto M; Kasumi F; Ogata E
Jpn J Clin Oncol; 2001 Jun; 31(6):263-9. PubMed ID: 11463804
[TBL] [Abstract][Full Text] [Related]
4. Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain.
Koizumi M; Yoshimoto M; Kasumi F; Iwase T; Ogata E
BMC Cancer; 2010 Aug; 10():423. PubMed ID: 20704752
[TBL] [Abstract][Full Text] [Related]
5. Optimal surveillance for postoperative metastasis in breast cancer patients.
Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with health-related quality of life in a cohort of Spanish breast cancer patients.
Moro-Valdezate D; Buch-Villa E; Peiró S; Morales-Monsalve MD; Caballero-Gárate A; Martínez-Agulló Á; Checa-Ayet F; Ortega-Serrano J
Breast Cancer; 2014 Jul; 21(4):442-52. PubMed ID: 22926507
[TBL] [Abstract][Full Text] [Related]
7. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
8. Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients.
Koizumi M; Yoshimoto M; Kasumi F; Ogata E
Ann Oncol; 2003 Aug; 14(8):1234-40. PubMed ID: 12881385
[TBL] [Abstract][Full Text] [Related]
9. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment.
Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N
Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473
[TBL] [Abstract][Full Text] [Related]
10. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
Danforth DN; Zujewski J; O'Shaughnessy J; Riseberg D; Steinberg SM; McAtee N; Noone M; Chow C; Chaudhry U; Lippman M; Jacobson J; Okunieff P; Cowan KH
Ann Surg Oncol; 1998 Mar; 5(2):150-8. PubMed ID: 9527268
[TBL] [Abstract][Full Text] [Related]
11. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
12. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
[TBL] [Abstract][Full Text] [Related]
13. The incidence of bone metastasis after early-stage breast cancer in Canada.
Liede A; Jerzak KJ; Hernandez RK; Wade SW; Sun P; Narod SA
Breast Cancer Res Treat; 2016 Apr; 156(3):587-595. PubMed ID: 27083181
[TBL] [Abstract][Full Text] [Related]
14. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
15. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
[TBL] [Abstract][Full Text] [Related]
16. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
18. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer: A SEER Investigation of Less Aggressive Treatment in a Favorable Histology.
Fakhreddine MH; Haque W; Ahmed A; Schwartz MR; Farach AM; Paulino AC; Bonefas E; Miltenburg D; Niravath P; Butler EB; Teh BS
Am J Clin Oncol; 2018 Jun; 41(6):532-537. PubMed ID: 27819878
[TBL] [Abstract][Full Text] [Related]
20. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Chan A; Delaloge S; Holmes FA; Moy B; Iwata H; Harvey VJ; Robert NJ; Silovski T; Gokmen E; von Minckwitz G; Ejlertsen B; Chia SKL; Mansi J; Barrios CH; Gnant M; Buyse M; Gore I; Smith J; Harker G; Masuda N; Petrakova K; Zotano AG; Iannotti N; Rodriguez G; Tassone P; Wong A; Bryce R; Ye Y; Yao B; Martin M;
Lancet Oncol; 2016 Mar; 17(3):367-377. PubMed ID: 26874901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
